Event Details

Who is this event intended for?: Statisticians involved in or interested in evidence integration and Bayesian borrowing


What is the benefit of attending?: Learn about recent developments in evidence integration and Bayesian borrowing from key experts in the industry



Event overview: Integrating clinical trial evidence with external data such as historical or real-world data is critical in many indications for marketing authorization or health technology assessment bodies. In rare diseases, or small populations, this integration is an ethical necessity for powering studies. In many indications, the integration is also necessary for increasing precision in some subgroups or in some exploratory endpoints, or earlier in development to inform internal decision making. Finally, in indications with a rapidly evolving treatment landscape, head-to-head comparisons between all relevant therapies is only possible as indirect comparisons integrating clinical trial evidence with external data.


This webinar is organised by the RWD SIG and the Historical Data Sig. We will review recent methods, applications, and tools of integrating subject-level-data from clinical trial with external data using Bayesian methods and/or causal inference methods.

Speakers

  • Satrajit Roychoudhury (Executive Director of Pfizer Inc)

    Satrajit Roychoudhury

    Executive Director of Pfizer Inc

    Dr. Satrajit Roychoudhury is an Executive Director and Head of the Statistical Research and Innovation group in Pfizer Inc. He has 18+ years of extensive experience in working with different phases of clinical trials for drug and vaccine. His research interest includes survival analysis, use of model-based approaches and Bayesian methods in clinical trials. Satrajit is an elected Fellow of the American Statistical Association and recipient of Royal Statistical Society(RSS)/Statisticians in the Pharmaceutical Industry (PSI) Statistical Excellence in the Pharmaceutical Industry Award in 2023 and Young Statistical Scientist Award from the International Indian Statistical Association in 2019.

    view more
  • Isaac Gravestock (Statistical Engineering Lead at Roche)

    Isaac Gravestock

    Statistical Engineering Lead at Roche

    Isaac Gravestock PhD is a statistician and software developer who leads the Statistical Engineering team at Roche. His interests include Bayesian methodology for external and hybrid controls, causal inference for observation data using target trial emulation and statistical computing. Previously, he was part of the Real World Data Science group at Roche for 5 years designing and analysing studies using real-world and observational data.

    view more
  • Christina Fillmore (Data Scientist at GSK)

    Christina Fillmore

    Data Scientist at GSK

    Christina Fillmore formally trained as a statistician, but over her 8 years at GSK transitioned into a data scientist. With a keen interest in R, she's co-lead of the PHUSE CAMIS project and R/pharma Diversity Alliance. She maintains metacore, metatools, and beastt R packages. Her focus is on creating open-source packages that enable others to deliver studies faster.

    view more
  • Antonio Remiro-Azocar (Statistical Methodologist at Novo Nordisk)

    Antonio Remiro-Azocar

    Statistical Methodologist at Novo Nordisk

    Dr Antonio Remiro-Azócar is a statistical methodologist within the Methods and Outreach department in Novo Nordisk. His expertise lies in quantitative evidence synthesis, health technology assessment and data fusion. Prior to his current role, Antonio was lead statistician for health technology assessment at Bayer and an independent contractor providing statistical support to contract research organizations. Antonio holds a PhD in Statistical Science and an MSc in Machine Learning from University College London.

    view more

Community

Connect with 473 people attending this event

Tickets

PSI Member
Member Price Complimentary
PSI Non-Member
Standard Price Complimentary